Leadership perspectives: Reflecting on key trends and challenges with Puneet Sarin
20 Dec 2024
In this insightful interview, Puneet Sarin, President of Specialty Diagnostics at Thermo Fisher Scientific, discusses key trends and challenges in the diagnostics industry. Sarin reflects on his diverse career across diagnostics and med tech, highlighting the industry's shift toward automation, AI, and personalized medicine. Sarin addresses the impacts of the COVID-19 pandemic on diagnostic readiness, the role of novel biomarkers, and the decentralization of testing. As laboratories face staffing shortages and cost pressures, innovations in diagnostics and regulatory partnerships are driving forward critical improvements in patient care.
This interview was recorded for #CLINICAL24 2024.
About the company
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
